Literature DB >> 21622862

A role for IL-27 in limiting T regulatory cell populations.

Elia D Tait Wojno1, Nancy Hosken, Jason S Stumhofer, Aisling C O'Hara, Elizabeth Mauldin, Qun Fang, Laurence A Turka, Steven D Levin, Christopher A Hunter.   

Abstract

IL-27 is a cytokine that regulates Th function during autoimmune and pathogen-induced immune responses. Although previous studies have shown that regulatory T cells (Tregs) express the IL-27R, and that IL-27 inhibits forkhead box P3 upregulation in vitro, little is known about how IL-27 influences Tregs in vivo. The studies presented in this article show that mice that overexpress IL-27 had decreased Treg frequencies and developed spontaneous inflammation. Although IL-27 did not cause mature Tregs to downregulate forkhead box P3, transgenic overexpression in vivo limited the size of a differentiating Treg population in a bone marrow chimera model, which correlated with reduced production of IL-2, a vital cytokine for Treg maintenance. These data identify an indirect role for IL-27 in shaping the Treg pool.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622862      PMCID: PMC3119737          DOI: 10.4049/jimmunol.1004182

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.

Authors:  Stefan Pflanz; Linda Hibbert; Jeanine Mattson; Rency Rosales; Elena Vaisberg; J Fernando Bazan; Joseph H Phillips; Terrill K McClanahan; Rene de Waal Malefyt; Robert A Kastelein
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity.

Authors:  David Artis; Alejandro Villarino; Michael Silverman; Weimian He; Elizabeth M Thornton; Sharon Mu; Shamin Summer; Todd M Covey; Elaine Huang; Hiroki Yoshida; Gary Koretzky; Michael Goldschmidt; Gary D Wu; Fred de Sauvage; Hugh R P Miller; Christiaan J M Saris; Phillip Scott; Christopher A Hunter
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

3.  Control of B cell development by Ras-mediated activation of Raf.

Authors:  B M Iritani; K A Forbush; M A Farrar; R M Perlmutter
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

Authors:  V L Godfrey; J E Wilkinson; L B Russell
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.

Authors:  Sophie Lucas; Nico Ghilardi; Ji Li; Frédéric J de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

6.  IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells.

Authors:  Linda Hibbert; Stefan Pflanz; Rene De Waal Malefyt; Robert A Kastelein
Journal:  J Interferon Cytokine Res       Date:  2003-09       Impact factor: 2.607

7.  Interleukin-2 is essential for CD4+CD25+ regulatory T cell function.

Authors:  Maurus de la Rosa; Sascha Rutz; Heike Dorninger; Alexander Scheffold
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

8.  WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production.

Authors:  Shinjiro Hamano; Kunisuke Himeno; Yoshiyuki Miyazaki; Kazunari Ishii; Atsushi Yamanaka; Atsunobu Takeda; Manxin Zhang; Hajime Hisaeda; Tak W Mak; Akihiko Yoshimura; Hiroki Yoshida
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

9.  IL-27 promotes T cell-dependent colitis through multiple mechanisms.

Authors:  Jennifer H Cox; Noelyn M Kljavin; Nandhini Ramamoorthi; Lauri Diehl; Marcel Batten; Nico Ghilardi
Journal:  J Exp Med       Date:  2010-12-20       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  43 in total

1.  IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.

Authors:  Reiko Horai; Mary J Mattapallil; Wai Po Chong; Phyllis B Silver; Jun Chen; Ru Zhou; Yuri Sergeev; Rafael Villasmil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-09-07       Impact factor: 7.094

2.  Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.

Authors:  Xiaotong Zhu; Zhihao Liu; Jin-Qing Liu; Jianmin Zhu; Jianchao Zhang; Jonathan P Davis; Jianhong Chu; Jianhua Yu; Jie Zhou; Ming-Song Li; Xue-Feng Bai
Journal:  J Leukoc Biol       Date:  2016-04-22       Impact factor: 4.962

Review 3.  Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.

Authors:  Caroline Andrews; Mairi H McLean; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 4.  IL-12 family cytokines: immunological playmakers.

Authors:  Dario A A Vignali; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

5.  Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

Authors:  Jin-Qing Liu; Zhenzhen Liu; Xuejun Zhang; Yun Shi; Fatemeh Talebian; Joseph W Carl; Chuan Yu; Fu-Dong Shi; Caroline C Whitacre; Joanne Trgovcich; Xue-Feng Bai
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

6.  Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Authors:  Ludovic Belle; Kimberle Agle; Vivian Zhou; Cheng Yin-Yuan; Richard Komorowski; Daniel Eastwood; Brent Logan; Jie Sun; Nico Ghilardi; Daniel Cua; Calvin B Williams; Melanie Gaignage; Reece Marillier; Jacques van Snick; William R Drobyski
Journal:  Blood       Date:  2016-08-03       Impact factor: 22.113

7.  Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Authors:  Jeongsu Do; Dongkyun Kim; Sohee Kim; Alice Valentin-Torres; Nina Dvorina; Eunjung Jang; Vivekananthan Nagarajavel; Tara M DeSilva; Xiaoxia Li; Angela H Ting; Dario A A Vignali; Stephen A Stohlman; William M Baldwin; Booki Min
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

8.  Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.

Authors:  Zhenzhen Liu; Jin-Qing Liu; Yun Shi; Xiaotong Zhu; Zhihao Liu; Ming-Song Li; Jianhua Yu; Lai-Chu Wu; Yukai He; Guoqiang Zhang; Xue-Feng Bai
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

9.  Impact of Interleukin-27p28 on T and B Cell Responses during Toxoplasmosis.

Authors:  Jeongho Park; Jonathan H DeLong; James J Knox; Christoph Konradt; Elia D Tait Wojno; Christopher A Hunter
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 10.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.